Henry Young

Henry E. Young, PhD, is the Chief Science Officer at the Dragonfly Foundation for Research and Development, a position he has held since September 2016. Based in Macon, Georgia, he coordinates research activities that focus on both basic science and clinical trials involving endogenous adult telomerase-positive stem cells. His work primarily targets chronic terminal diseases and traumatic injuries, exploring therapies for a wide range of conditions including neurodegenerative and autoimmune disorders.12

Educational Background

• Bachelor of Science in Biology: Ohio State University (1974)
• Master of Science in Zoology: University of Arkansas (1977)
• PhD in Anatomy: Texas Tech Health Sciences Center (1983)
• Completed postdoctoral fellowships in carbohydrate biochemistry and developmental biology at Case Western University.23

Professional Experience

• Chief Science Officer: Dragonfly Foundation for Research and Development (2016 - Present)
• Adjunct Professor of Pediatrics: Mercer University School of Medicine (2004 - 2012)
• Research and Development Scientist: Dragonfly Foundation (1976 - 2016)
• Co-founded several biotechnology companies focused on stem cell research.12

Research Contributions

Dr. Young is recognized for his significant contributions to stem cell biology, including the discovery of various types of stem cells and their applications in regenerative medicine. He has authored numerous publications and has received several awards throughout his career, including the Albert Nelson Marquis Lifetime Achievement Award.234

Affiliations

He is a member of several prestigious organizations such as the American Association for the Advancement of Science and the International Society for Stem Cell Research. His research has been featured in prominent media outlets, including National Public Radio.2